
View larger version (31K):
[in a new window]
|
Fig. 3. Tou physically interacts with Pnr. (A) Structural features of the Pnr and
Tou proteins used in the present study. The DNA binding domain of Pnr
(PnrDBD), containing the two zinc fingers (grey boxes) and the
C-terminal domain (PnrCT) containing the two amphipathic
-helices (black boxes). The mutations associated with
pnrD1 and with pnrVX1 are localized
within the N-terminal zinc finger and in the N terminus of the helices
respectively. A schematic drawing of the Tou domains used throughout this
study (TouA to TouK). The functional domains of Tou are schematized as in
Fig. 1. (B) Tou physically
interacts with Pnr in yeast, through both the DBD and the C-terminus of Pnr.
Expression vectors for unfused LexADBD(-) or
LexADBDPnrDBD, LexADBDPnrCT,
LexADBDPnrWT, LexADBDPnrD1,
LexADBDPnrVX1 were introduced into L40 cells together
with the unfused VP16AD (not shown) or VP16ADTouA.
Protein extracts made from cultured L40 transformants were assayed for
ß-galactosidase activity (expressed in nanomoles of substrate/mn/mg of
protein). Values (±10%) are the averages of three independent
experiments. (C,D) Tou physically interacts with (C) full-length Pnr, (D) the
DBD of Pnr and the C terminus (CT) of Pnr in transfected cells. In each case,
an immunoblot of a representative set of transfected cell extracts is shown.
The transfected expression vectors are shown at the top of the panels. The B10
monoclonal antibody used to immunoprecipitate the extracts is shown on the
left of the panels. The antibodies used to reveal the blots are indicated at
the bottom. Pnr is recognized by the 2B8 antibody, GSTPnrDBD and
GSTPnrCT are detected by the D10 antibody and the B10-tagged TouA
is recognized by the B10 antibody. The locations of the proteins including the
immunoglobulin heavy chain [IgG(H)] are indicated at the sides. (E) Tou
directly interacts both with the DBD and the CT of Pnr in vitro. (E)
Autoradiographs of SDS-PAGE gels from representative affinity chromatography
experiments performed with GST control beads (lane 2), GSTPnrDBD
beads (lane 3) and GSTPnrCT beads (lane 4) and in vitro translated
35S proteins as indicated on the left. One-tenth of the
35S input is shown in lane 1. Luciferase is used as a negative
input. Experiments were performed three times and, with all proteins except
luciferase, 50-fold more protein bound to GSTPnrDBD and
GSTPnrCT than to GST control. (F) The N terminus of the MBD domain
of Tou mediates interaction with Pnr. Expression vectors for unfused
LexADBD (not shown) or LexADBDPnrWT were
introduced in L40 cells together with the unfused VP16AD (not
shown) or VP16ADTouA, VP16ADTouC, VP16ADTouD,
VP16ADTouJ or VP16ADTouK. Protein extracts made from
cultured L40 transformants were assayed for ß-galactosidase activities
(expressed in nanomoles of substrate/mn/mg of protein). Values (±10%)
are the averages of three independent experiments.
|